E, A., C, A., V, T., A, E., GP, C., S, C., . . . F, S. (2024). Cardiac risk and myocardial fibrosis assessment with cardiac magnetic resonance in patients with myotonic dystrophy. Frontiers in neurology, 15, 1493570. https://doi.org/10.3389/fneur.2024.1493570
Chicago Style (17th ed.) CitationE, Abati, Alberti C, Tambè V, Esseridou A, Comi GP, Corti S, Meola G, and Secchi F. "Cardiac Risk and Myocardial Fibrosis Assessment with Cardiac Magnetic Resonance in Patients with Myotonic Dystrophy." Frontiers in Neurology 15 (2024): 1493570. https://doi.org/10.3389/fneur.2024.1493570.
MLA (9th ed.) CitationE, Abati, et al. "Cardiac Risk and Myocardial Fibrosis Assessment with Cardiac Magnetic Resonance in Patients with Myotonic Dystrophy." Frontiers in Neurology, vol. 15, 2024, p. 1493570, https://doi.org/10.3389/fneur.2024.1493570.